bit.bio Wins Honours for Innovation in Synthetic Biology and Exceptional Business Growth
CAMBRIDGE, UK, September 12, 2024: bit.bio, the company coding human cells for novel cures and a pioneer in the field of synthetic biology, today announced it has won Life Science Innovation awards at the 34th annual Business Weekly Awards 2024. The prestigious awards, celebrating excellence in the East of England's business community, were presented last night at a gala dinner held at Queens’ College, Cambridge.
“These awards are a testament to bit.bio's groundbreaking work in cell programming and our rapid growth in the biotechnology sector. Our opti-ox technology is transforming drug discovery and disease research by providing consistent, scalable human cells. This recognition fuels our commitment to democratise access to human cells, accelerate the development of novel therapies, and ultimately improve patients' lives.”
Life Science Innovation award celebrates the company's significant growth and innovation in the cell programming space.
Dr. Hermann Hauser, renowned tech entrepreneur, co-founder of Acorn Computers and Arm, delivered the keynote address. Dr. Hauser shared key insights for companies within the Cambridge Cluster aspiring to achieve global growth. His remarks emphasised the region’s role as a world-leading innovation hub and the immense potential for further advancements in the life sciences and technology sectors.
The Business Weekly Awards, established in 1990, are a highlight of the regional business calendar, attracting entries from across Cambridgeshire, Suffolk, Norfolk, Bedfordshire, Essex, and Hertfordshire. The awards are supported by prominent sponsors, including Mills & Reeve, AstraZeneca, Arm, PwC, and Barclays, among others. This year's awards also saw the introduction of the Cambridge Tech Week Award, reflecting the region’s growing influence in the technology sector.